Myriad Genetics (MYGN) Free Cash Flow Growth (5y) (2014 - 2026)
Myriad Genetics (MYGN) Free Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.39% |
| Dec 31, 2025 | 15.69% |
| Sep 30, 2025 | 16.62% |
| Jun 30, 2025 | -16.90% |
| Mar 31, 2025 | -28.95% |
| Dec 31, 2024 | -33.34% |
| Sep 30, 2024 | -16.84% |
| Jun 30, 2024 | -17.56% |
| Mar 31, 2024 | -48.65% |
| Dec 31, 2023 | -27.41% |
| Sep 30, 2023 | -45.03% |
| Jun 30, 2023 | -13.29% |
| Mar 31, 2023 | -53.75% |
| Dec 31, 2022 | -22.05% |
| Sep 30, 2022 | -24.04% |
| Jun 30, 2022 | -28.99% |
| Mar 31, 2022 | -27.23% |
| Dec 31, 2021 | -19.58% |
| Sep 30, 2021 | -63.37% |
| Mar 31, 2021 | 7.44% |